Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism SphK inhibitors(Sphingosine kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H39ClN2O |
InChIKeyPVMAZYMPOPETMY-RXQQAGQTSA-N |
CAS Registry2986742-97-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Preclinical | CN | 01 Feb 2021 |